Ross DeVol is chief research officer at the Milken Institute. He oversees research on international, national and comparative regional growth performance; technology and its impact on regional and national economies; access to capital and its role in economic growth and job creation; and health-related topics. Recent work involves research on global economic and financial market conditions. He was the principal author of �The Global Biomedical Industry: Preserving U.S. Leadership,� a study that showed that the United States is still the global leader in the biomedical industry, but countries across Europe and Asia are pursuing aggressive plans to close the gap and take the high-value jobs and capital this sector creates. He was also the principal author of "An Unhealthy America: The Economic Burden of Chronic Disease," which brought to light the economic losses associated with preventable illnesses and estimated the avoidable costs if a serious effort were made to improve Americans� health. In addition, he authored "America�s High-Tech Economy: Growth, Development and Risks for Metropolitan Areas" and created the "Best-Performing Cities Index," an annual ranking of U.S. metropolitan areas that shows where jobs are being created. DeVol is ranked among the "Super Stars" of Think Tank Scholars by International Economy magazine. DeVol was previously senior vice president of Global Insight Inc.
Like what you see? Make sure you're getting it all
Authoritative coverage, data and analysis of deals across structured finance markets